Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 7796023)

Published in Br J Surg on March 01, 1995

Authors

D Cherqui1, R Alon, P Piedbois, C Duvoux, D Dhumeaux, M Julien, P L Fagniez

Author Affiliations

1: Department of Digestive Surgery, Hôpital Henri Mondor, Université Paris XII, Créteil, France.

Articles by these authors

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science (1999) 8.43

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol (2000) 4.25

Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature (1996) 4.19

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79

Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol (2001) 3.38

The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood (2000) 3.30

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet (2000) 3.27

Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg (2000) 3.01

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol (2000) 2.98

The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest (1999) 2.98

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis (1995) 2.89

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol (1992) 2.86

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology (1994) 2.45

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol (2004) 2.24

Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med (2000) 2.21

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol (1998) 2.05

Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins. Proc Natl Acad Sci U S A (1997) 2.01

Mechanism of phenobarbital-induced hypercholeresis in the rat. Am J Physiol (1970) 1.99

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst (1996) 1.93

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88

Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol (1998) 1.84

Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology (1995) 1.78

Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant (2011) 1.75

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut (2003) 1.74

Hepatitis C virus in dermatology. A review. Arch Dermatol (1995) 1.71

Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1). J Cell Biol (1995) 1.67

Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut (2002) 1.65

Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg (1989) 1.64

Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet (1991) 1.64

Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. Gut (1997) 1.64

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation (2002) 1.64

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol (1996) 1.59

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol (1998) 1.59

Sialylated, fucosylated ligands for L-selectin expressed on leukocytes mediate tethering and rolling adhesions in physiologic flow conditions. J Cell Biol (1996) 1.58

Surgery for biliary obstruction by tumour thrombus in primary liver cancer. Br J Surg (1996) 1.57

Common bile duct stricture as a late complication of upper abdominal radiotherapy. J Hepatol (1994) 1.56

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology (1997) 1.55

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med (1995) 1.53

Specialized functional properties of the integrin alpha 4 cytoplasmic domain. Mol Biol Cell (1995) 1.53

Standardization of hepatitis C virus RNA quantification. Hepatology (2000) 1.52

Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol (2003) 1.52

Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood (1999) 1.51

The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity (1996) 1.51

Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol (1991) 1.50

Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology (2000) 1.49

Effect of inhibitors of sodium transport on bile formation in the rabbit. Am J Physiol (1970) 1.49

Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol (1990) 1.47

Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci (2000) 1.47

Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci (1989) 1.46

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology (1999) 1.45

Residual organic debris on processed surgical instruments. AORN J (1995) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J (2005) 1.40

Impact of smoking on histological liver lesions in chronic hepatitis C. Gut (2003) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol (1996) 1.38

Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg (2000) 1.37

Bile duct cysts in adults: a multi-institutional retrospective study. French Associations for Surgical Research. Ann Surg (1998) 1.37

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology (1998) 1.36

High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow. J Immunol (1999) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg (1993) 1.34

High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol (1995) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg (1998) 1.27

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol (1999) 1.26

Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol (1994) 1.26

Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods (2000) 1.26

Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol (1998) 1.25

Dynamic CT features of hepatic abscesses. Radiology (1985) 1.23

Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation. Ann Surg (2001) 1.23

Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann Surg (1999) 1.22

Cytoplasmic anchorage of L-selectin controls leukocyte capture and rolling by increasing the mechanical stability of the selectin tether. J Cell Biol (2001) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology (1977) 1.19

The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J Immunol (2000) 1.19

What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods (1997) 1.19

An activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flow. J Biol Chem (2000) 1.18

Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol (1996) 1.18

Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology (1995) 1.18

Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18

Ileocolonic anastomosis after right hemicolectomy for carcinoma: stapled or hand-sewn? A prospective, multicenter, randomized trial. Int J Colorectal Dis (1993) 1.17

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Gut (2004) 1.16

Mechanisms and control of secretion of bile water and electrolytes. Gastroenterology (1974) 1.15

On the relationship between response to treatment and survival time. Stat Med (1996) 1.15

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. J Infect Dis (1996) 1.14

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol (2001) 1.13

Drug-induced vascular lesions of the liver. Arch Intern Med (1983) 1.13

Association of focal nodular hyperplasia and hepatic hemangioma. Gastroenterology (1989) 1.13

Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology (1993) 1.12

Cutaneous phaeohyphomycosis caused by Veronaea bothryosa in a liver transplant recipient successfully treated with itraconazole. Clin Infect Dis (1999) 1.12